fbpx

Essilor® Launches National Campaign to Strengthen Awareness of Myopia Among Parents in Canada

According to a recent survey of Canadian parents, over 70% of them are unaware of myopia – or nearsightedness – and its impact on their children’s educational success.

Identifying the need to improve that awareness, Essilor® is launching “Eyes on the Future,” a national campaign across Canada to encourage parents to protect their children’s eyesight by educating and driving action to book eye exams with independent ECPs for their children and give eye care professionals the resources to better diagnose and slow down myopia progression and other eye conditions.

Almost half of those surveyed also did not identify their child’s need for corrective lenses until the child is already struggling. It is estimated that by 2050, half of the world population is predicted to be myopic. 

“As a world leader in vision care, it is Essilor’s responsibility to play a leading role in the fight against myopia, and it’s apparent that many parents across Canada are unfortunately unaware of the impact that myopia can have on children,” said Nicola Courtemanche, Vice President, Optical, Independents, EssilorLuxottica Canada. “With myopia cases among children increasing, eye exams done at an earlier age are critical to identifying issues and treating early to reduce myopia’s impact on children’s futures. That’s why we’re invested to ensure parents make seeing an eye care professional for their children a top priority.”

The “Eyes on the Future” consumer campaign speaks directly to Canadian parents through a variety of multimedia platforms with celebrity influencers and key opinion leaders sharing stories of the families and children impacted by myopia. The campaign has the opportunity to reach over 13.5 million media impressions. Parents will learn that catching myopia early is key and highlight the positive difference eye care professionals can play in their children’s life, with treatments to correct their vision and slow the progression of myopia, specifically with the new Essilor® Stellest® lenses.

“When we saw that more than 81% of parents surveyed have brought their child to the dentist within the past year, but only 52% have taken them to the eye doctor in the same timeframe, this makes our “Eyes on the Future” campaign so much more important,” said Bordeleau-Tassile.

Essilor® is committed to supporting eye care professionals in the continued fight against myopia. A productivity incentive for Essilor® Stellest® is now available, starting August 1, 2023, to December 31, 2023, independent eye care professionals will have the opportunity to earn rebates as they increase their sales of Essilor® Stellest® lenses.

For more details and information, independent eye care professionals are encouraged to speak with their Essilor® Business Consultants. Support materials are also available, including in-depth educational content on the innovative lens through the Leonardo learning platform.

Essilor® Leading with Innovative Eye Solutions for Myopia

Essilor® launched a new lens in Canada in early 2022 called Essilor® Stellest®, which has been proven to slow down myopia progression by 67% on average, compared to single vision lenses when worn 12 hours a day.

The efficacy of the Essilor® Stellest® lenses has been further bolstered by the four-year clinical trial results of Essilor’s myopia control innovation Essilor® Stellest® lens, which were presented at the ARVO annual meeting in New Orleans, Louisiana, United States, in April 2023.

The findings show that Essilor® Stellest® lenses continue to exhibit strong efficacy in slowing myopia progression and axial eye elongation in children in the fourth year. The new data follows the recent publication of the three-year clinical trial findings in the medical journal American Journal of Ophthalmology, which also highlights evidence of continued myopia control efficacy of the lens in slowing down myopia progression in children over three years. The link to the article can be found here.

Click HERE for the full press release.

For more related articles on Optik NOW, click HERE.

Featured Posts

IRIS, The Visual Group logo

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Learn More
Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read more
Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read more
Centre for Ocular Research & Education (CORE)

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the University of Waterloo have entered into a strategic partnership to advance vision science research and therapeutic development, as well as to enhance eye care delivery on a global scale.

Read more
Silhouette Titan Minimal Art Sun

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

Read more
IRIS, The Visual Group logo

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Learn More
Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read More
Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read More
Centre for Ocular Research & Education (CORE)

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the University of Waterloo have entered into a strategic partnership to advance vision science research and therapeutic development, as well as to enhance eye care delivery on a global scale.

Read More
Silhouette Titan Minimal Art Sun

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

Read More
IRIS, The Visual Group logo

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Learn More
Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read more
Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read more
Centre for Ocular Research & Education (CORE)

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the University of Waterloo have entered into a strategic partnership to advance vision science research and therapeutic development, as well as to enhance eye care delivery on a global scale.

Read more
Silhouette Titan Minimal Art Sun

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

Read more
IRIS, The Visual Group logo

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Learn More
Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read more
Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read more
Centre for Ocular Research & Education (CORE)

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the University of Waterloo have entered into a strategic partnership to advance vision science research and therapeutic development, as well as to enhance eye care delivery on a global scale.

Read more
Silhouette Titan Minimal Art Sun

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

Read more